Table 1 Dose constraints employed during the planning process
TT | 3DCRT /3DCRT-DIBH | |
|---|---|---|
Mean Age Tumor stage | 55.5 (± 5.8) | 61.6 (± 9.4) |
pTis | 0 | 4 |
pT1a | 1 | 4 |
pT1b | 9 | 6 |
pT1c | 15 | 9 |
pT2 | 5 | 1 |
PT3 | 0 | 1 |
ypT0 | 0 | 5 |
Tumor quadrant | ||
Upper outer | 16 | 14 |
Upper inner | 4 | 5 |
Retro/perimammillary | 6 | 5 |
Lower outer | 3 | 4 |
Lower inner | 1 | 2 |
Type of surgery | ||
BCS | 30 | 29 |
mastectomy (immediate reconstruction) | 0 | 1 |
Boost | simultaneous | Sequential |
Boost dose | 28 × 2.25 Gy | 5 × 2 Gy (n = 4) 8 × 2 Gy (n = 26) |
Site of treatment | ||
left | 15 (50%) | 30 (100%) |
right | 15 (50%) | 0 (0%) |